Review article: long‐term safety of oral anti‐viral treatment for chronic hepatitis B

E-ISSN： 1365-2036|47|6|730-737

ISSN： 0269-2813

Source： ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.47, Iss.6, 2018-03, pp. : 730-737

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The long‐term effects of anti‐TNF‐α agents on patients with chronic viral hepatitis C and B infections

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (ELECTRONIC), Vol. 18, Iss. 1, 2015-01 ,pp. : 40-45

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term safety of oral nucleos(t)ide analogs for patients with chronic hepatitis B: A cohort study of 53,500 subjects

HEPATOLOGY, Vol. 62, Iss. 3, 2015-09 ,pp. : 684-693

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety of long‐term biologic therapy in rheumatologic patients with a previously resolved hepatitis B viral infection

HEPATOLOGY, Vol. 62, Iss. 1, 2015-07 ,pp. : 40-46

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cirrhosis regression by lamivudine

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 2, 2015-02 ,pp. : 372-378

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long‐term entecavir or tenofovir disoproxil fumarate therapy in treatment‐naïve chronic hepatitis B patients in the real‐world setting

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 5, 2015-05 ,pp. : 504-510

John Wiley & Sons Inc

Access to resources Recommend Favorite